# Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain

> **NCT04778592** · PHASE2 · COMPLETED · sponsor: **Eliem Therapeutics (UK) Ltd.** · enrollment: 149 (actual)

## Conditions studied

- Lumbosacral Radiculopathy

## Interventions

- **DRUG:** ETX-018810
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04778592
- **Lead sponsor:** Eliem Therapeutics (UK) Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-19
- **Primary completion:** 2022-05-16
- **Final completion:** 2022-05-25
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2023-11-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04778592

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04778592, "Efficacy and Safety of ETX-018810 in Subjects With Lumbosacral Radicular Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04778592. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*